GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia

Brain Research Reviews

Volumn 31, Issue 2-3, 2000, Pages 270-276

  Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Chandelier neuron; GABA membrane transporter; Glutamic acid decarboxylase; Mediodorsal thalamus; Parvalbumin; Pyramidal cell

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CARRIER PROTEIN; GAT 1; GLUTAMATE DECARBOXYLASE; PARVALBUMIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; BRAIN DYSFUNCTION; BRAIN NERVE CELL; CELL DENSITY; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MENTAL DISEASE; NERVE CELL NETWORK; NERVE ENDING; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PERIKARYON; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SYNAPSE;

GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURAL PATHWAYS; NEURONS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 0034098526     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00042-9     Document Type: Conference Paper

References (51)

1. A receptor subunit gene expression in human prefrontal cortex: Comparison of schizophrenics and controls. Cereb. Cortex. 5:1995;550-560.
2. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry. 52:1995;258-266.
3. Anderson S.A., Classey J.D., Condé F., Lund J.S., Lewis D.A. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience. 67:1995;7-22.
4. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 24:1997;349-355.
5. Benes F.M., Snyder-Marie A., Vincent S., Khan Y. Up-regulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031.
6. Benson D.L., Huntsman M.M., Jones E.G. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb. Cortex. 4:1994;40-51.
7. Bird E.D., Spokes E.G.S., Iversen L.L. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain. 102:1979;347-360.
8. Bourgeois J.-P., Goldman-Rakic P.S., Rakic P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb. Cortex. 4:1994;78-96.
9. Condé F., Lund J.S., Jacobowitz D.M., Baimbridge K.G., Lewis D.A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k, or parvalbumin in monkey prefrontal cortex: Distribution and morphology. J. Comp. Neurol. 341:1994;95-116.
10. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 59:1995;81-96.
11. 2a receptors in schizophrenia. Soc. Neurosci. Abstr. 24:1998;1274.
12. DeFelipe J., Hendry S.H.C., Jones E.G. Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc. Natl. Acad. Sci. USA. 86:1989;2093-2097.
13. del Río M.R., DeFelipe J. Synaptic connections of calretinin-immunoreactive neurons in the human neocortex. J. Neurosci. 17:1997;5143-5154.
14. A. Fairen, J. DeFelipe, J. Regidon, Nonpyramidal neurons, general account, in: A. Peters and E.G. Jones (Eds.), Cerebral Cortex, Vol. 1., Plenum, New York, 1984, pp. 201-245.
15. J.M. Fuster, The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe, third ed., Lippincott-Raven, Philadelphia, 1997
16. Gabbott P.L.A., Bacon S.J. Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: II. Quantitative areal and laminar distributions. J. Comp. Neurol. 364:1996;609-636.
17. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R.E., Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry. 65:1998;446-453.
18. Gilbert C.D., Kelly J.P. The projections of cells in different layers of the cat's visual cortex. J. Comp. Neurol. 63:1975;81-106.
19. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
20. Glantz L.A., Lewis D.A. Specificity of decreased spine density on layer III pyramidal cells in schizophrenia. Soc. Neurosci. Abstr. 22:1996;1679.
21. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: Regional and diagnostic specificity. Arch. Gen. Psychiatry. 54:1997;943-952.
22. Goldman-Rakic P.S. Cellular basis of working memory. Neuron. 14:1995;477-485.
23. 3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci. 40:1987;239-266.
24. Hendry S.H.C., Jones E.G. Activity-dependent regulation of GABA expression in the visual cortex of adult monkeys. Neuron. 1:1988;701-712.
25. Huntsman M.M., Tran B.V., Potkin S.G., Bunney W.E., Jones E.G. Altered ratios of alternatively spliced long and short gamma 2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc. Natl. Acad. Sci. USA. 95:1998;15066-15071.
26. Isaacson J.S., Solis J.M., Nicoll R.A. Local and diffuse synaptic action of GABA in the hippocampus. Neuron. 10:1993;165-175.
27. Lewis D.A. Chandelier cells: Shedding light on altered cortical circuitry in schizophrenia. Mol. Psychiatry. 3:1998;468-471.
28. Lewis D.A., Anderson S.A. The functional architecture of the prefrontal cortex and schizophrenia. Psychol. Med. 25:1995;887-894.
29. Lewis D.A., Lund J.S. Heterogeneity of chandelier neurons in monkey neocortex: Corticotropin-releasing factor and parvalbumin immunoreactive populations. J. Comp. Neurol. 293:1990;599-615.
30. Lund J.S., Lewis D.A. Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J. Comp. Neurol. 328:1993;282-312.
31. Lund J.S., Lund R.D., Hendrickson A.E., Bunt A.H., Fuchs A.F. The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase. J. Comp. Neurol. 164:1975;287-304.
32. Mager S., Naeve J., Quick M., Labarca C., Davidson N., Lester H.A. Steady states, charge movements, and rates for a cloned GABA transporter expressed in xenopus ocytes. Neuron. 10:1993;177-188.
33. Manaye K.F., Liang C.-L., Hicks P.B., German D., Young K.A. Nerve cell numbers in thalamic anterior and mediodorsal nuclei are selectively reduced in schizophrenia. Soc. Neurosci. Abstr. 24:1998;1236.
34. D.S. Melchitzky, S.R. Sesack, D.A. Lewis, Parvalbumin-immunoreactive axon terminals in monkey and human prefrontal cortex: Laminar, regional and target specificity of Type I and Type II synapses, J. Comp. Neurol. (1999) in press.
35. Minelli A., Brecha N.C., Karschin C., DeBiasi S., Conti F. GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J. Neurosci. 15:1995;7734-7746.
36. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 47:1990;1023-1028.
37. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol. Psychiatry. 34:1993;768-772.
38. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch. Gen. Psychiatry. 49:1992;975-982.
39. A receptor subunit expression in schizophrenic prefrontal cortex. Soc. Neurosci. Abstr. 24:1998;1274.
40. A. Peters, Chandelier cells, in: E.G. Jones and A. Peters (Eds.), Cerebral Cortex, Vol. 1., Plenum Press, New York, 1984, pp. 361-380.
41. J.N. Pierri, A.S. Chaudry, T.-U. Woo, D.A. Lewis, Decreased GAT-1 -immunoreactive chandelier cell axon terminals in the prefrontal cortex in schizophrenia: Diagnostic and laminar specificity, Schizophr. Res. (1998) in press.
42. Popken G.J., Bunney W.E., Potkin S.G., Jones E.G. Neuron number and GABAergic and glutamatergic mRNA expression in subdivisions of the thalamic mediodorsal nucleus of schizophrenics. Soc. Neurosci. Abstr. 24:1998;991.
43. Reynolds G.P., Czudek C., Andrews H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol. Psychiatry. 27:1990;1038-1044.
44. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 52:1995;805-818.
45. Sesack S.R., Hawrylak V.A., Melchitzky D.S., Lewis D.A. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: Ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. Cereb. Cortex. 8:1998;614-622.
46. Sherman A.D., Davidson A.T., Baruah S., Hegwood T.S., Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci. Lett. 121:1991;77-80.
47. Simpson M.D.C., Slater P., Deakin J.F.W., Royston M.C., Skan W.J. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci. Lett. 107:1989;211-215.
48. 67 mRNA in a subpopulation of GABA neurons in the prefrontal cortex of schizophrenic subjects. Soc. Neurosci. Abstr. 24:1998;986.
49. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry. 43:1986;114-124.
50. Woo T.-U., Miller J.L., Lewis D.A. Parvalbumin-containing cortical neurons in schizophrenia. Am. J. Psychiatry. 154:1997;1013-1015.
51. Woo T.-U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA. 95:1998;5341-5346.